Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

A new systematic review evaluates the current and potential application of Quality by Design (QbD) in the development of nanocosmetics and cosmeceuticals. Following predefined inclusion and exclusion ...

AI-enabled QC shifts assurance from retrospective release testing to real-time control, leveraging anomaly detection, root-cause acceleration, and virtual witnessing across labs, manufacturing, and ...